European Neuropsychopharmacology
Volume 20, Issue 5 , Pages 281-287 , May 2010

Does subtle disturbance of neuronal migration contribute to schizophrenia and other neurodevelopmental disorders? Potential genetic mechanisms with possible treatment implications

  • Stephen I. Deutsch

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Psychiatry and Behavioral Sciences, Eastern Virginia Medical School, 825 Fairfax Avenue, Suite 710, Norfolk, Virginia 23507-1912, USA. Tel.: +1 757 446 5888; fax: +1 757 446 5918.
    • ,
  • Jessica A. Burket
    • ,
  • Elionora Katz

Received 15 December 2009 ,Revised 22 January 2010 ,Accepted 3 February 2010.

References 

  1. Akahane A, Kuynugi H, Tanaka H, Nanko S. Association analysis of polymorphic CGG repeat in 5′ UTR of the reelin and VLDLR genes with schizophrenia. Schizophr. Res. 2002;58:37–41
  2. Bock HH, Herz J. Reelin activates Src family tyrosine kinases in neurons. Curr. Biol. 2003;13:18–26
  3. Boycott KM, Flavelle S, Bureau A, Glass HC, Fujiwara TM, Wirrell E, et al. Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification. Am. J. Hum. Genet. 2005;77:477–483
  4. Boycott KM, Parboosingh JS, Chodirker BN, Lowry RB, McLeod DR, Morris J, et al. Clinical genetics and the Hutterite population: a review of Mendelian disorders. Am. J. Med. Genet. 2008;146A(8):1088–1098
  5. Boycott KM, Bonnemann C, Herz J, Neuert S, Beaulieu C, Scott JN, et al. Mutations in VLDLR as a cause for autosomal recessive cerebellar ataxia with mental retardation (disequilibrium syndrome). J. Child Neurol. 2009;24(10):1310–1315
  6. Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, Hariri AR, et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2005;102(24):8627–8632
  7. Davies N, Russell A, Jones P, Murray RM. Which characteristics of schizophrenia predate psychosis?. J. Psychiatr. Res. 1998;32:121–131
  8. Deutsch SI, Rosse RB, Lakshman RM. Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of Alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2006;30:1369–1380
  9. Deutsch SI, Rosse RB, Mastropaolo J, Long KD, Gaskins BA. Epigenetic therapeutic strategies for the treatment of neuropsychiatric disorders: ready for prime time?. Clin. Neuropharmacol. 2008;31(2):104–119
  10. Deutsch SI, Schwartz BL, Rosse RB, Mastropaolo J, Fanous AH, Weizman A, et al. Schizophrenia endophenotypes as treatment targets. In:  Ritsner MS editors. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes. Dordrecht, Netherlands: Springer; 2009;p. 113–122
  11. Deutsch SI, Burket JA, Rosse RB, Schwartz BL. Genetic variation of chromosome 1q42: etiologic mechanism of congenital disorders of neuronal migration and synaptogenesis. Curr. Psychiatry Rev. 2009;5(4):236–249
  12. Deutsch, S.I., Rosse, R.B., Schwartz, B.L., Mastropaolo, J., Burket, J.A., Weizman, A., in press. Regulation of intermittent oscillatory activity of pyramidal cell neurons by GABA inhibitory interneurons is impaired in schizophrenia: rational for pharmacotherapeutic GABAergic interventions. Isr. J. Psychiatry.
  13. Dewachter I, Ris L, Jaworski T, Seymour CM, Kremer A, Borghgraef P, et al. GSK3beta, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at serine-9. Neurobiol. Dis. 2009;35(2):193–200
  14. Ekelund J, Lichtermann D, Hovatta I, Ellonen P, Suvisaari J, Terwilliger JD, et al. Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum. Mol. Genet. 2000;9(7):1049–1057
  15. Fatemi SH. Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Mol. Psychiatry. 2001;6:129–133
  16. Garrido JJ, Simón D, Varea O, Wandosell F. GSK3 alpha and GSK3 beta are necessary for axon formation. FEBS Lett. 2007;581(8):1579–1586
  17. Grunblatt E, Salkovic-Petrisi M, Osmanovic J, Riederer P, Hoyer S. Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J. Neurochem. 2007;101:757–770
  18. Guidotti A, Auta J, Davis JM, Dwivedi Y, Gerevini VD, Impagnatiello F, et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study. Arch. Gen. Psychiatry. 2000;57:1061–1069
  19. Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, et al. Direct binding of reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron. 1999;24:481–489
  20. Hong SE, Shugart YY, Huang DT, Al Shahwan A, Grant PE, Hourihane JO, et al. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat. Genet. 2000;26:93–96
  21. Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 1998;95(26):15718–15723
  22. Jope RS, Roh MS. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr. Drug Targets. 2006;7(11):1421–1434
  23. Koike H, Arguello PA, Kvajo M, Karayiorgou M, Gogos JA. Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc. Natl. Acad. Sci. U. S. A. 2006;103(10):3693–3697
  24. Kozlovsky N, Belmaker RH, Agam G. GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur. Neuropsychopharmacol. 2002;12(1):13–25
  25. Kvajo M, McKellar H, Arguello PA, Drew LJ, Moore H, MacDermott AB, et al. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neural architecture and cognition. Proc. Natl. Acad. Sci. U. S. A. 2008;105(19):7076–7081
  26. Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G. Tau interacts with src-family non-receptor tyrosine kinases. J. Cell Sci. 1998;111:3167–3177
  27. Li X, Rosborough KM, Friedman AB, Zhu W, Roth KA. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. Int. J. Neuropsychopharmacol. 2007;10(1):7–19
  28. Liu WS, Pesold C, Rodriguez MA, Carboni G, Auta J, Lacor P, et al. Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc. Natl. Acad. Sci. U. S. A. 2001;98(6):3477–3482
  29. Mao Y, Ge X, Frank CL, Madison JM, Koehler AN, Doud MK, et al. DISC1 regulates neural progenitor proliferation via modulation of GSK3β/β-catenin signaling. Cell. 2009;136(6):1017–1031
  30. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 2000;9:1415–1423
  31. Moheb LA, Tzschach A, Garshasbi M, Kahrizi K, Darvish H, Heshmati Y, et al. Identification of a nonsense mutation in the very low-density lipoprotein receptor gene (VLDLR) in an Iranian family with dysequilibrium syndrome. Eur. J. Hum. Genet. 2008;16:270–273
  32. Ozcelik T, Akarsu N, Uz E, Caglayan S, Gulsuner S, Onat OE, et al. Mutations in the very low-density lipoprotein receptor VLDLR cause cerebellar hypoplasia and quadrupedal locomotion in humans. Proc. Natl. Acad. Sci. U. S. A. 2008;105(11):4232–4236
  33. Rice DS, Curran T. Mutant mice with scrambled brains: understanding the signaling pathways that control cell positioning in the CNS. Genes Dev. 1999;13:2758–2773
  34. Roh MS, Seo MS, Kim Y, Kim SH, Jeon WJ, Ahn YM, et al. Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex. Exp. Mol. Med. 2007;39(3):353–360
  35. Shen S, Lang B, Nakamoto C, Zhang F, Pu J, Kuan SL. Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J. Neurosci. 2008;28(43):10893–10904
  36. Suzuki K, Nakamura K, Iwata Y, Sekine Y, Kawai M, Sugihara G, et al. Decreased expression of reelin receptor VLDLR in peripheral lymphocytes of drug-naïve schizophrenic patients. Schizophr. Res. 2008;98:148–156
  37. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, et al. Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and apoE receptor 2. Cell. 1999;97:689–701
  38. Turkmen S, Hoffmann K, Demirhan O, Aruoba D, Humphrey N, Mundlos S. Cerebellar hypoplasia, with quadrupedal locomotion, caused by mutations in the very low-density lipoprotein receptor gene. Eur. J. Hum. Genet. 2008;16:1070–1074
  39. Vallee RB, Tsai JW. The cellular roles of the lissencephaly gene LIS1, and what they tell us about brain development. Genes Dev. 2006;20(11):1384–1393
  40. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 1987;44:660–669

PII: S0924-977X(10)00024-6

doi: 10.1016/j.euroneuro.2010.02.005

European Neuropsychopharmacology
Volume 20, Issue 5 , Pages 281-287 , May 2010

Article Tools